Abstract
Gene editing technologies, such as CRISPR-Cas9, have revolutionized the field of biomedical engineering by enabling precise modifications of the human genome. These advancements have the potential to transform medicine by offering solutions for genetic disorders, cancer therapy, and personalized medicine. However, the application of gene editing also raises significant ethical questions, particularly concerning the implications for human genetics, consent, and long-term effects. This article explores the potential of gene editing technologies in biomedical engineering and examines the ethical considerations that must be addressed to ensure their responsible use.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Dr. Alice Johnson, Dr. Mark Roberts (Author)